When preparing for the launch of a new product, medical device manufacturers should also evaluate whether their technologies will have a foundation to build on two to three years down the line.

I am honored to testify in these hearings on “Medicaid Prescription Drugs: Examining Options for Payment Reform,” held by the Committee on Energy and Commerce’s Subcommittee on Health. I am a Resident ...

The Food and Drug Administration designates as “breakthrough” technologies certain drugs and devices. This designation helps expedite the development and review of therapies intended to treat serious ...

WASHINGTON (AP) — The Supreme Court said Wednesday that the federal government improperly lowered drug reimbursement payments to hospitals and clinics that serve low-income communities, a reduction ...

Since 2019, states have enacted prescription drug affordability boards (PDAB) with the asserted intention of lowering drug spending and improving affordability for patients. Variability across states ...

In its slogan, BeiGene says that “cancer has no borders.” It’s a different story in Europe, however, where the influence of multiple regulatory agencies and discrete reimbursement processes can turn ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. WASHINGTON (AP) — The Supreme Court said ...